Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flexible progestin-primed ovarian stimulation in polycystic ovary syndrome
IRCT20180528039878N2Phase 3Completed
- Sponsor
- Mehr Medical Institute
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydroxyprogesterone caproate in female infertility and polycystic ovary syndrome (PCOS), sponsored by Mehr Medical Institute. Started Jun 2021; status: completed.
02
Drugs
hydroxyprogesterone caproate
03
Conditions
female infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20180528039878N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180528039878N2.